Skip to main content
. 2023 Apr 10;7(4):348–351. doi: 10.1177/24741264231163396

Figure 3.

Figure 3.

Serial ultrasound images show progressive resolution of the choroidal lesion. On initial evaluation (A) the choroidal lesion with fluid in Tenon space was 5.2 mm in maximum thickness, decreasing to 2.5 mm 2 days after pembrolizumab discontinuation (B), and complete resolution of lesion and fluid in Tenon space was noted 14 days later (C).